Brief: Scibase Barrier Technology Part Of Immunodermatology Project

SciBase Holding AB (publ)

23/03/2022 14:06

March 23 (Reuters) - SciBase Holding AB (publ)  SCIB.ST :
    * SCIBASE BARRIER TECHNOLOGY PART OF MAJOR IMMUNODERMATOLOGY
PROJECT
    * NEXT GENERATION IMMUNODERMATOLOGY (NGID) CONSORTIUM IS
BASED IN
NETHERLANDS AND WILL RUN OVER 6 YEARS
    * CONSORTIUM HAS RECEIVED FUNDING OF 11.7M EUROS TO
STIMULATE AND
SUPPORT INNOVATIVE APPROACHES TO IDENTIFY AND DEVELOP NOVEL
DIAGNOSTIC AND THERAPEUTIC APPROACHES WITHIN DERMATOLOGY

Source text for Eikon:  ID:nWkrFpr8g 
Further company coverage:  SCIB.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))